Detalhe da pesquisa
1.
Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study.
Haematologica
; 2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38497158
2.
Impact of minimal residual disease response and of status of disease on survival after blinatumomab in B-cell acute lymphoblastic leukemia: results from a real-life study.
Ann Hematol
; 2024 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38609726
3.
A phase 2 study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse large B-cell lymphoma.
Blood
; 137(5): 600-609, 2021 02 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33538797
4.
Predictive value on advance hodgkin lymphoma treatment outcome of end-of treatment FDG PET/CT in the HD0607 clinical trial.
Hematol Oncol
; 41(3): 415-423, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36534947
5.
A phase 2, multicentre, open-label trial (ACE-LY-003) of acalabrutinib in patients with relapsed or refractory marginal zone lymphoma.
Br J Haematol
; 199(1): 76-85, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35861370
6.
Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: A Fondazione Italiana Linfomi real-life experience.
Hematol Oncol
; 40(1): 31-39, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34694649
7.
Whole-body magnetic resonance imaging (WB-MRI) in lymphoma: State of the art.
Hematol Oncol
; 38(1): 12-21, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31486520
8.
Early serum TARC reduction predicts prognosis in advanced-stage Hodgkin lymphoma patients treated with a PET-adapted strategy.
Hematol Oncol
; 38(4): 501-508, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32602970
9.
Lenalidomide in Pretreated Patients with Diffuse Large B-Cell Lymphoma: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice.
Oncologist
; 24(9): 1246-1252, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30940746
10.
The metronomic all-oral DEVEC is an effective schedule in elderly patients with diffuse large b-cell lymphoma.
Invest New Drugs
; 37(3): 548-558, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31028663
11.
Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial.
Haematologica
; 104(11): 2241-2248, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31666344
12.
Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study.
Br J Haematol
; 183(5): 755-765, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30407629
13.
A phase II multicenter study of the anti-CD19 antibody drug conjugate coltuximab ravtansine (SAR3419) in patients with relapsed or refractory diffuse large B-cell lymphoma previously treated with rituximab-based immunotherapy.
Haematologica
; 103(8): 1351-1358, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29748443
14.
Whole body magnetic resonance in indolent lymphomas under watchful waiting: The time is now.
Eur Radiol
; 28(3): 1187-1193, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29018927
15.
Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma.
Haematologica
; 102(11): 1931-1935, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28775121
16.
Whole-body MRI, FDG-PET/CT, and bone marrow biopsy, for the assessment of bone marrow involvement in patients with newly diagnosed lymphoma.
J Magn Reson Imaging
; 45(4): 1082-1089, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27603267
17.
Osteonecrosis detected by whole body magnetic resonance in patients with Hodgkin Lymphoma treated by BEACOPP.
Eur Radiol
; 27(5): 2129-2136, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27519911
18.
Whole-body MRI in patients with lymphoma: collateral findings.
Radiol Med
; 121(10): 793-800, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27307001
19.
BRAF mutations in hairy-cell leukemia.
N Engl J Med
; 364(24): 2305-15, 2011 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-21663470
20.
Allogeneic Stem Cell Transplantation in Refractory Acute Myeloid Leukaemia.
Cells
; 13(9)2024 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38727291